RxDoctor Payments Data

Jill Cavish, NP

Psychiatric/Mental Health · Anaheim, CANPI 1669499588

Payments from drug & device makers

$1,988in general payments, 2019–2025

Across 82 payments — averaging $24.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Indivior Inc.$466
  • Neurocrine Biosciences, Inc.$364
  • Teva Pharmaceuticals USA, Inc.$349
  • Johnson & Johnson$316
  • Alkermes, Inc.$160
  • Vanda Pharmaceuticals Inc.$156
  • plus $177 from 3 others

What the payments were for

  • Food & beverage$1,91396%
  • Education$754%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,988 in reported general payments places this provider in the 80th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Medicare billing

Part B allowed, 2024
$18,098
Medicare patients
26
Services billed
174

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate136$470,464
Abilify MaintenaAripiprazole35$97,947
Olanzapine230$9,244
Aripiprazole91$8,791
Quetiapine Fumarate208$3,259
Divalproex Sodium ErDivalproex Sodium84$2,901
Clozapine12$1,623
Olanzapine OdtOlanzapine41$1,560
Benztropine Mesylate116$1,353
Risperidone138$1,078
Haloperidol33$912
Bupropion XlBupropion Hcl27$855
Divalproex Sodium38$813
Clomipramine Hcl12$769
Quetiapine Fumarate ErQuetiapine Fumarate27$683

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$316$470,464136 claims
Otsuka America Pharmaceutical, Inc.Abilify Maintena$74$97,94735 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,433 psychiatric/mental health providers in California.

Other psychiatric/mental health in Anaheim

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →